90 related articles for article (PubMed ID: 26791850)
1. Immune Targeting in Gastrointestinal Malignancies: Finding the Right Combination for the Right Site.
Manji GA
Oncology (Williston Park); 2016 Jan; 30(1):91-3. PubMed ID: 26791850
[No Abstract] [Full Text] [Related]
2. Modern Immunotherapy for the Treatment of Advanced Gastrointestinal Cancers.
Khalil DN; Segal NH
Oncology (Williston Park); 2016 Jan; 30(1):85-90, 93. PubMed ID: 26791849
[TBL] [Abstract][Full Text] [Related]
3. Advances in the management of gastrointestinal cancers--an upcoming role of immune checkpoint blockade.
Goel G; Sun W
J Hematol Oncol; 2015 Jul; 8():86. PubMed ID: 26174086
[TBL] [Abstract][Full Text] [Related]
4. Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancers.
Bashir B; Flickinger JC; Snook AE
Immunotherapy; 2021 May; 13(7):561-564. PubMed ID: 33724866
[TBL] [Abstract][Full Text] [Related]
5. [The analysis of CCR4+/CXCR3+ cell ratio in gastrointestinal cancer patients receiving chemotherapy or immunotherapy].
Sakuyama R; Aruga A; Kuramochi H; Matsushita N; Kotera Y; Takeshita S; Hayashi K; Yamamoto M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2259-61. PubMed ID: 19106589
[TBL] [Abstract][Full Text] [Related]
6. Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research.
Bhargava A; Mishra D; Banerjee S; Mishra PK
J Drug Target; 2013 Feb; 21(2):126-36. PubMed ID: 23061479
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy a Likely New Standard for GI Cancers.
Cancer Discov; 2021 Jan; 11(1):8. PubMed ID: 33239268
[TBL] [Abstract][Full Text] [Related]
8. Reactivating effect of levamisole on cell-mediated immunity in gastrointestinal cancer patients.
Miwa H; Orita K
Acta Med Okayama; 1977 Oct; 31(5):325-9. PubMed ID: 146404
[TBL] [Abstract][Full Text] [Related]
9. Immune-based therapies in pancreatic and colorectal cancers and biomarkers of responsiveness.
Di Caro G; Castino GF; Bergomas F; Cortese N; Chiriva-Internati M; Grizzi F; Marchesi F
Expert Rev Anticancer Ther; 2014 Oct; 14(10):1219-28. PubMed ID: 25222571
[TBL] [Abstract][Full Text] [Related]
10. Clinical experiences with G17DT in gastrointestinal malignancies.
He AR; Marshall JL
Expert Rev Anticancer Ther; 2006 Apr; 6(4):487-92. PubMed ID: 16613537
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen.
Itoh T; Ueda Y; Kawashima I; Nukaya I; Fujiwara H; Fuji N; Yamashita T; Yoshimura T; Okugawa K; Iwasaki T; Ideno M; Takesako K; Mitsuhashi M; Orita K; Yamagishi H
Cancer Immunol Immunother; 2002 Apr; 51(2):99-106. PubMed ID: 11904734
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal immunotherapy to prevent peritoneal carcinomatosis in patients with advanced gastrointestinal malignancies.
Ströhlein MA; Heiss MM
J Surg Oncol; 2009 Sep; 100(4):329-30. PubMed ID: 19697440
[TBL] [Abstract][Full Text] [Related]
13. Initial observations on the administration of thymus extract (TFX) in patients with alimentary tract neoplasms.
Cybulski L; Turowski G; Politowski M; Urban A; Turaszwili T; Zubel M
Pol Med Sci Hist Bull (1973); 1976; 15(1):47-9. PubMed ID: 995755
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of gastrointestinal cancer patients with levamisole.
Miwa H; Orita K
Acta Med Okayama; 1979 Feb; 33(1):29-42. PubMed ID: 155980
[TBL] [Abstract][Full Text] [Related]
15. Adoptive immunotherapy in gastrointestine malignancies using interleukin-2. Current results and future prospects.
Marshall GD
Acta Chir Scand Suppl; 1989; 549():71-4. PubMed ID: 2784605
[No Abstract] [Full Text] [Related]
16. Immunotherapy of gastrointestinal cancer: the potential.
Sparks FC; Ramming KP
Clin Gastroenterol; 1976 Sep; 5(3):855-68. PubMed ID: 798647
[No Abstract] [Full Text] [Related]
17. The effect of large dose intratumoral administration of OK-432 in advanced cancer patients.
Sakamoto J; Kondo T; Kamei H; Ichihashi H; Yamamura Y
Nagoya J Med Sci; 1979 Dec; 42(1-2):27-36. PubMed ID: 530302
[No Abstract] [Full Text] [Related]
18. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.
Sasada T; Kimura M; Yoshida Y; Kanai M; Takabayashi A
Cancer; 2003 Sep; 98(5):1089-99. PubMed ID: 12942579
[TBL] [Abstract][Full Text] [Related]
19. [Immunotherapy of digestive cancers].
Hoerni B
Med Chir Dig; 1972; 1(1):29-32. PubMed ID: 5054002
[No Abstract] [Full Text] [Related]
20. Cancer immunotherapy with levamisole.
Miwa H; Orita K
Acta Med Okayama; 1978 Jul; 32(3):239-45. PubMed ID: 151489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
